Latest Content

Understanding Recent Treatment Advancements in Kidney Cancer Care

September 22nd 2025, 7:00pm

By Ryan Scott

Article

Dr. Ravi Munver sat down for an interview with CURE to discuss progress in kidney cancer care.

Aging Out of AYA Cancer Survivorship

September 22nd 2025, 5:00pm

By Danielle Ripley-Burgess

Article

I was diagnosed with colon cancer at 17, and while I’ll always be part of the AYA community, turning 40 has shown me the gift of growing older.

Being Diagnosed With Breast Cancer at 29: A Patient’s Perspective

September 22nd 2025, 4:00pm

By Alex Biese

Article

CURE spoke with nurse and breast cancer survivor Amanda Davis at the John Theurer Cancer Center.

Giredestrant Plus Afinitor Improves Outcomes in ER-Positive Breast Cancer

September 22nd 2025, 3:01pm

By Spencer Feldman

Article

Giredestrant plus Afinitor improved survival without progression in ER-positive advanced breast cancer.

Stem Cell and Cellular Therapy Insights for Patients With Blood Cancer

September 22nd 2025, 1:00pm

By Dr. Christina Cho

Video

Dr. Christina Cho highlights the Adult Stem Cell Transplant and Cellular Therapy Program for its innovative research and compassionate, multidisciplinary team.

Patient Perspectives on Learning About Their HNSCC

September 22nd 2025, 12:05pm

By Glenn Hanna, MD

Video

Panelists discuss how thorough monitoring led to the discovery of asymptomatic throat cancer in a patient with HPV, emphasizing the importance of maintaining fitness, building support networks, and adopting a positive attitude throughout the cancer journey despite multiple recurrences.

Expert Overview of Recurrent/Metastatic HNSCC

September 22nd 2025, 12:00pm

By Glenn Hanna, MD

Video

Panelists discuss how recurrent metastatic head and neck squamous cell carcinoma (HNSCC) manifests through symptoms such as persistent sore throat and neck lumps, with risk factors including tobacco use, alcohol consumption, and HPV infection, particularly affecting patients in their 50s and 60s who lacked access to preventive HPV vaccination.

MDS Treatment Advances: Targeted Therapies and Anemia Management

September 21st 2025, 2:00pm

By Spencer Feldman

Article

Learn how myelodysplastic syndrome treatment has advanced with targeted therapies and anemia management while balancing quality of life for patients.

For Young Adults, A Cancer Diagnosis ‘Doesn’t Define Who You Are’

September 20th 2025, 6:00pm

By Amanda Davis

Video

After receiving a breast cancer diagnosis at 29, Amanda Davis wants other young adults who are patients to know that “brighter days are coming.”

Lung Cancer Can Affect Anyone, Even Non-Smokers

September 20th 2025, 6:00pm

By Natalie Brown

Article

It is very important to let the world know that no matter how healthy you think you are, if you have lungs, you can potentially develop lung cancer.

Advances in Kidney Cancer Allow Less Invasive and More Personalized Care

September 20th 2025, 2:00pm

By Dr. Ravi Munver

Video

Kidney cancer care has seen advances over the past few decades, reflecting both improved diagnostic capabilities and less invasive treatment approaches.

MNV-201 Secures FDA Fast Track Designation in Myelodysplastic Syndrome

September 19th 2025, 9:00pm

By Ryan Scott

Article

The U.S. FDA has granted fast track designation to the investigational therapy MNV-201 for the treatment of myelodysplastic syndrome.

Non-Melanoma Skin Cancer: An Overview From Diagnosis to Treatment

September 19th 2025, 8:00pm

By Alex Biese

Article

Non-melanoma skin cancer is a common and highly treatable type of cancer that originates in the top layer of the skin, like basal cell carcinoma.

FDA Approves Subcutaneous Keytruda in Adult and Pediatric Solid Tumors

September 19th 2025, 6:54pm

By Ryan Scott

Article

The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.

Welcome to a Survivor’s Yard

September 19th 2025, 5:00pm

By Felicia Mitchell

Article

Many of the choices I've made regarding yard maintenance relate to my hopes to mitigate the risk of more cancer.